Risk of endometrial cancer after tamoxifen treatment of breast cancer-Reference-Cited by-同舟云学术

Risk of endometrial cancer after tamoxifen treatment of breast cancer

Published:1994-02 Issue:8895 Volume:343 Page:448-452
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

van Leeuwen F.E.,van den Belt-Dusebout A.W.,van Leeuwen F.E.,Benraadt J.,Diepenhorst F.W.,van Tinteren H.,Coebergh J.W.W.,Kiemeney L.A.L.M.,Gimbrère C.H.F.,Otter R.,Schouten L.J.,Damhuis R.A.M.,Benraadt J.,Bontenbal M.

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women;Early Breast Cancer Trialists' Collaborative Group;Lancet,1992

2. Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer;Adjuvant Breast Trial Working Party;Br J Cancer,1988

3. A randomized trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors;Fisher;N Engl J Med,1989

4. Adjuvant tamoxifen in early breast cancers: occurrence of new primary cancers;Fornander;Lancet,1989

5. Prevention of breast cancer with tamoxifen: an update on the Royal Marsden pilot programme;Powles;Eur J Cancer,1990

Cited by 539 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnological Advances in the Diagnosis of Gynecological Cancers and Nanotheranostics;Current Pharmaceutical Design;2024-09

2. Comparative effects of progestin-based combination therapy for endometrial cancer or atypical endometrial hyperplasia: a systematic review and network meta-analysis;Frontiers in Oncology;2024-05-03

3. Evaluation of pre-therapeutic imaging work-up in the staging of endometrial cancer: Interest in a systematic second opinion in a cancer center;Journal of Gynecology Obstetrics and Human Reproduction;2024-02

4. Anticancer drugs from hormones and vitamins;Natural Products as Anticancer Agents;2024

5. X-ray crystallography study and optimization of novel benzothiophene analogs as potent selective estrogen receptor covalent antagonists (SERCAs) with improved potency and safety profiles;Bioorganic Chemistry;2023-12